PSDV - pSivida Limited Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited

PSDV 1.220

+14.0%

Mar 29 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	7/13/2015 11:15:36 PM
	of 421

JULY 13, 2015 pSivida Corp. (NASDAQ:PSDV) shares have been given a 1 rating by analysts surveyed by Zacks Investment Research. Sell-side firms often use different terminology for their ratings so this scale provides a simple consensus number. The ratings are calculated on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. When analysts were polled three months ago, the stock had an average rating of 1. Sell-Side brokerage firms have a price target of $9 on shares of pSivida Corp. (NASDAQ:PSDV). This is based on analysts one year projections on the stock. The most bearish analyst outlook has a price target of $8, while the most aggressive firm sees the stock reaching $10 within the year. http://www.investornewswire.com/analyst-views/psivida-corp-nasdaqpsdv-analyst-rating-in-focus/20601/

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next